Frequently Asked Questions
The global mycobacterium infections treatment market is projected to grow at a CAGR of 6.50% during the forecast period of 2022-2029.
Factors such as increased cases of mycobacterium abscessus and growing demand for advanced diagnostic techniques are acting as the major drivers for the global mycobacterium infections treatment market.
Asia-Pacific dominates the market due to the critical generic players and increased focus on research and development activity.
North America has witnessed positive growth for the global mycobacterium infections treatment market throughout the forecasted period due to the high prevalence of infectious diseases, sophisticated medical facilities, and government initiatives.
